Revenue: The sum of all revenue fields included for a company's operating activities.
Seres Therapeutics, Inc. (MCRB) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$32.68M |
|
-- |
|
-- |
|
$27.24M |
|
$-27.24M |
|
$59.92M |
|
$32.68M |
|
$32.68M |
|
$32.68M |
|
$32.68M |
|
$32.68M |
|
$32.68M |
|
$-27.24M |
|
$-26.16M |
|
8.70M |
|
8.71M |
|
$3.76 |
|
$3.75 |
|
| Balance Sheet Financials | |
$66.08M |
|
$10.55M |
|
$98.10M |
|
$164.18M |
|
$31.32M |
|
-- |
|
$82.39M |
|
$113.72M |
|
$50.47M |
|
$50.47M |
|
$50.47M |
|
8.73M |
|
| Cash Flow Statement Financials | |
$26.91M |
|
$-0.03M |
|
$1.18M |
|
$39.46M |
|
$67.52M |
|
$28.06M |
|
$2.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$26.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.76% |
|
64.76% |
|
19.91% |
|
64.76% |
|
$5.78 |
|
$3.08 |
|
$3.09 |
|